Literature DB >> 21669301

Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain.

Patricia Gavín1, María José Iglesias, María Soledad Jiménez, Elena Rodríguez-Valín, Daniel Ibarz, María Antonia Lezcano, María José Revillo, Carlos Martín, Sofía Samper.   

Abstract

The data presented here span 11 years (1998-2008) of monitoring of multidrug-resistant tuberculosis (MDR-TB) clustering through molecular typing techniques in Spain. The molecular and epidemiological data of 480 multidrug-resistant Mycobacterium tuberculosis complex isolates were analyzed. Thirty-one clusters involving 157 (32.7%) patients were identified. The proportion of immigrants increased substantially over the study period reaching 65% in 2008; however, the clustering rate remained stable indicating that local transmission was little influenced by imported MDR-TB. The three major clusters respond to the persistence of two autochthonous strains throughout the study period and an extensively drug-resistant (XDR) Mycobacterium bovis outbreak with only two cases was reported since 2002. Molecular and epidemiological evidence for the importation of new strains and their spread within the community was found. Immigrant-only clusters most often grouped patients infected abroad with strains belonging to rare spoligotypes. Conversely, widespread spoligotypes of the Latin-American and Mediterranean (LAM) and Haarlem families were responsible for the majority of the MDR-TB local transmission. The demonstration of clusters spanning several Spanish regions that have been ongoing throughout the study period makes it advisable to maintain a continuous molecular surveillance in order to monitor the spread of MDR-TB.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669301     DOI: 10.1016/j.meegid.2011.05.016

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

1.  Evolution and transmission patterns of extensively drug-resistant tuberculosis in China.

Authors:  Feifei Wang; Lingyun Shao; Xiaoping Fan; Yaojie Shen; Ni Diao; Jialin Jin; Feng Sun; Jing Wu; Jiazhen Chen; Xinhua Weng; Xunjia Cheng; Ying Zhang; Wenhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil.

Authors:  Rodrigo Ivan Prim; Marcos André Schörner; Simone Gonçalves Senna; Christiane Lourenço Nogueira; Anna Carolina Cançado Figueiredo; Jaquelline Germano de Oliveira; Darcita Bürger Rovaris; Maria Luiza Bazzo
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-07       Impact factor: 2.743

4.  Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China.

Authors:  Chijioke A Nsofor; Qi Jiang; Jie Wu; Mingyu Gan; Qingyun Liu; Tianyu Zuo; Guofeng Zhu; Qian Gao
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

5.  The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain.

Authors:  María José Iglesias; Daniel Ibarz; Alberto Cebollada; Jéssica Comín; María Soledad Jiménez; María C Vázquez; Sofía Samper
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

6.  Single nucleotide polymorphism (SNP) analysis used for the phylogeny of the Mycobacterium tuberculosis complex based on a pyrosequencing assay.

Authors:  Adriana Cabal; Mark Strunk; José Domínguez; María Antonia Lezcano; María Asunción Vitoria; Miguel Ferrero; Carlos Martín; María José Iglesias; Sofía Samper
Journal:  BMC Microbiol       Date:  2014-02-03       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.